KMTS

Kestra Medical Technologies, Ltd.

Price Chart

Latest Quote

$22.58

+0.50 (+2.26%)

Current Price

Previous Close	$22.08
Open	$22.06
Day High	$23.27
Day Low	$21.79
Volume	318,785

Fetched: 2026-06-26T02:17:16

Stock Information

Shares Outstanding	58.37M
Total Debt	$46.55M
Cash Equivalents	$291.32M
Revenue	$83.72M
Net Income	$-148.12M
Sector	Healthcare
Industry	Medical Instruments & Supplies
Market Cap	$1.32B
EPS (TTM)	$-5.46
Exchange	NMS

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$1.07B
Sales	$83.72M
Income	$-148.12M
Book/sh	$4.94
Cash/sh	$4.99
Employees	330

Financial Ratios

Quick Ratio	7.08
Current Ratio	7.32
Debt/Eq	16.16

Returns & Margins

ROA	-36.84%
ROE	-92.65%
Gross Margin	48.75%
Operating Margin	-141.60%
Profit Margin	-172.99%

Ownership

Insider Ownership	5.34%
Institutional Ownership	102.87%
Insider & Institutional transactions data not available

Valuation Ratios

Forward P/E	-10.55
P/S	15.74
P/B	4.57

Analyst Data

Recommendation	none
Target Price	$27.71

Technical Indicators

SMA20	$20.25
SMA50	$20.94
SMA200	$23.37
RSI	62.09
ATR	1.4164

Shares Float	32.75M
Short Float	9.30%
Short Ratio	11.01
Rel Volume	1.05

Performance History

Week	+18.34%
Month	+3.48%
Quarter	+9.72%
6 Months	-19.39%
YTD	-7.42%
Year	+28.00%
10 Years	+3.39%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-06-25	$22.58	318,785
2026-06-24	$22.08	311,400
2026-06-23	$20.69	235,900
2026-06-22	$20.73	288,000
2026-06-18	$19.93	398,800
2026-06-17	$19.08	280,300
2026-06-16	$19.23	152,100
2026-06-15	$20.41	292,200
2026-06-12	$20.85	358,100
2026-06-11	$20.14	138,400
2026-06-10	$19.44	261,700
2026-06-09	$19.92	396,900
2026-06-08	$19.74	275,000
2026-06-05	$19.40	315,000
2026-06-04	$20.45	569,300
2026-06-03	$18.82	491,900
2026-06-02	$18.82	318,000
2026-06-01	$20.19	209,800
2026-05-29	$21.26	228,400
2026-05-28	$21.25	207,300
2026-05-27	$21.00	147,200
2026-05-26	$21.82	301,400

About Kestra Medical Technologies, Ltd.

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company's develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its platform provides ASSURE WCD, a wearable cardioverter defibrillator used to protect patients at an elevated risk of sudden cardiac arrest; and a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

📰 Latest News

Assessing Kestra Medical Technologies (KMTS) Valuation After Recent Share Price Weakness

Simply Wall St. • 2026-03-29T01:06:47Z

Kestra Medical Technologies Q3 Earnings Call Highlights

MarketBeat • 2026-03-18T21:47:35Z

KESTRA MEDICAL TECHNOLOGIES, LTD. Q3 2026 Earnings Call Summary

Moby • 2026-03-18T12:30:00Z

Kestra Medical Technologies Ltd (KMTS) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ...

GuruFocus.com • 2026-03-18T03:01:23Z

Kestra Medical Technologies Ltd (KMTS) Q3 2026: Everything You Need To Know Ahead Of Earnings

GuruFocus.com • 2026-03-16T13:16:17Z

Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value

Simply Wall St. • 2026-01-18T13:15:09Z

Kestra Medical Technologies Ltd (KMTS) Q2 2026 Earnings Call Highlights: Revenue Surge and ...

GuruFocus.com • 2025-12-12T05:00:37Z

Assessing Kestra Medical Technologies (KMTS) Valuation After Its Recent Share Price Pullback

Simply Wall St. • 2025-12-08T04:19:59Z

Kestra Medical Technologies (KMTS): Assessing Valuation After Recent Surge in Share Price

Simply Wall St. • 2025-10-10T15:11:47Z

Kestra Medical Technologies Ltd (KMTS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...

GuruFocus.com • 2025-09-12T07:04:17Z

Period:

Income Statement (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30	2021-04-30
Revenue
Reconciled Cost Of Revenue	$35,605,000	$27,452,000	$18,281,000	-
Cost Of Revenue	$35,605,000	$27,452,000	$18,281,000	-
Total Revenue	$59,815,000	$27,814,000	$7,630,000	$0
Operating Revenue	$59,815,000	$27,814,000	$7,630,000	$0
Expenses
Interest Expense	$7,734,000	$6,230,000	$5,629,000	$1,168,000
Total Expenses	$166,193,000	$112,877,000	$88,051,000	$32,708,000
Other Income Expense	$-2,766,000	$-2,803,000	$1,827,000	$-38,000
Other Non Operating Income Expenses	$-118,000	$-2,803,000	$1,827,000	$-38,000
Net Non Operating Interest Income Expense	$-4,535,000	$-6,230,000	$-5,629,000	$-1,168,000
Interest Expense Non Operating	$7,734,000	$6,230,000	$5,629,000	$1,168,000
Operating Expense	$130,588,000	$85,425,000	$69,770,000	$32,708,000
Selling And Marketing Expense	-	$40,682,000	$34,919,000	$13,902,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Net Interest Income	$-4,535,000	$-6,230,000	$-5,629,000	$-1,168,000
Interest Income	$3,199,000	$0	-	-
Normalized Income	$-111,722,080	$-94,120,000	$-84,238,000	$-34,101,000
Net Income From Continuing And Discontinued Operation	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Total Operating Income As Reported	$-106,378,000	$-85,063,000	$-80,421,000	$-32,708,000
Net Income Common Stockholders	$-126,135,000	$-100,841,000	$-86,737,000	$-34,101,000
Net Income	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Net Income Including Noncontrolling Interests	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Net Income Continuous Operations	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Pretax Income	$-113,679,000	$-94,096,000	$-84,223,000	$-33,914,000
Interest Income Non Operating	$3,199,000	$0	-	-
Operating Income	$-106,378,000	$-85,063,000	$-80,421,000	$-32,708,000
Gross Profit	$24,210,000	$362,000	$-10,651,000	-
Per Share
Diluted EPS	$-5.13	$-5.07	$-4.36	$-1.71
Basic EPS	$-5.13	$-5.07	$-4.36	$-1.71
Other
Tax Effect Of Unusual Items	$-556,080	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-95,329,000	$-76,306,000	$-73,739,000	$-32,326,000
Total Unusual Items	$-2,648,000	-	-	-
Total Unusual Items Excluding Goodwill	$-2,648,000	-	-	-
Reconciled Depreciation	$7,968,000	$11,560,000	$4,855,000	$420,000
EBITDA (Bullshit earnings)	$-97,977,000	$-76,306,000	$-73,739,000	$-32,326,000
EBIT	$-105,945,000	$-87,866,000	$-78,594,000	$-32,746,000
Diluted Average Shares	$24,583,745	$19,885,382	$19,885,382	$19,885,382
Basic Average Shares	$24,583,745	$19,885,382	$19,885,382	$19,885,382
Diluted NI Availto Com Stockholders	$-126,135,000	$-100,841,000	$-86,737,000	$-34,101,000
Preferred Stock Dividends	$12,321,000	$6,721,000	$2,499,000	-
Tax Provision	$135,000	$24,000	$15,000	$187,000
Gain On Sale Of Security	$-2,648,000	-	-	-
Research And Development	$15,652,000	$15,490,000	$15,756,000	$18,806,000
Selling General And Administration	$114,936,000	$69,935,000	$54,014,000	$13,902,000
Minority Interests	-	$692,000	$0	-

Fetched: 2026-06-21

Balance Sheet (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30	2021-04-30
Assets
Net Tangible Assets	$205,406,000	$-209,377,000	$-117,578,000	$1,766,000
Total Assets	$295,744,000	$45,949,000	$38,656,000	$30,522,000
Total Non Current Assets	$40,416,000	$31,042,000	$20,233,000	$4,326,000
Other Non Current Assets	$1,487,000	$941,000	$868,000	$1,243,000
Non Current Prepaid Assets	$2,021,000	$1,710,000	$2,642,000	-
Current Assets	$255,328,000	$14,907,000	$18,423,000	$26,196,000
Other Current Assets	$1,693,000	$419,000	$370,000	$1,345,000
Prepaid Assets	$1,387,000	$951,000	$1,130,000	$509,000
Inventory	$6,572,000	$3,290,000	$2,113,000	-
Receivables	$8,081,000	$1,998,000	$0	-
Accounts Receivable	$8,081,000	$1,998,000	$0	-
Cash Cash Equivalents And Short Term Investments	$237,595,000	$8,249,000	$14,810,000	$24,342,000
Cash And Cash Equivalents	$237,595,000	$8,249,000	$14,810,000	$24,342,000
Other Receivables	-	$3,290,000	$2,113,000	-
Debt
Total Debt	$44,311,000	$45,169,000	$39,134,000	$22,849,000
Long Term Debt And Capital Lease Obligation	$44,124,000	$45,169,000	$17,322,000	$21,788,000
Long Term Debt	$41,098,000	$42,536,000	$17,322,000	$20,238,000
Current Debt And Capital Lease Obligation	$187,000	-	$21,812,000	$1,061,000
Net Debt	-	$34,287,000	$22,958,000	-
Current Debt	-	-	$20,446,000	-
Other Current Borrowings	-	-	$20,446,000	-
Liabilities
Total Liabilities Net Minority Interest	$90,338,000	$255,326,000	$156,234,000	$28,756,000
Total Non Current Liabilities Net Minority Interest	$52,361,000	$222,355,000	$119,495,000	$22,148,000
Other Non Current Liabilities	$140,000	$76,000	$63,000	$360,000
Derivative Product Liabilities	$8,097,000	$0	-	-
Current Liabilities	$37,977,000	$32,971,000	$36,739,000	$6,608,000
Payables And Accrued Expenses	$29,117,000	$26,777,000	$10,261,000	$5,547,000
Payables	$23,961,000	$23,892,000	$6,162,000	$1,741,000
Accounts Payable	$23,961,000	$23,892,000	$6,162,000	$1,699,000
Other Current Liabilities	-	$4,554,000	$5,375,000	-
Total Tax Payable	-	$234,000	$215,000	$42,000
Equity
Common Stock Equity	$205,406,000	$-209,377,000	$-117,578,000	$1,766,000
Total Equity Gross Minority Interest	$205,406,000	$-209,377,000	$-117,578,000	$1,766,000
Stockholders Equity	$205,406,000	$-209,377,000	$-117,578,000	$1,766,000
Retained Earnings	$-520,249,000	$-406,435,000	$-312,315,000	$-170,080,000
Preferred Securities Outside Stock Equity	$0	$177,110,000	$102,110,000	-
Other
Ordinary Shares Number	$51,348,656	$49,533,819	$49,533,819	$49,533,819
Share Issued	$51,348,656	$49,533,819	$49,533,819	$49,533,819
Tangible Book Value	$205,406,000	$-209,377,000	$-117,578,000	$1,766,000
Invested Capital	$246,504,000	$-166,841,000	$-79,810,000	$22,004,000
Working Capital	$217,351,000	$-18,064,000	$-18,316,000	$19,588,000
Capital Lease Obligations	$3,213,000	$2,633,000	$1,366,000	$2,611,000
Total Capitalization	$246,504,000	$-166,841,000	$-100,256,000	$22,004,000
Additional Paid In Capital	$674,306,000	$177,149,000	$194,736,000	$171,845,000
Capital Stock	$51,349,000	$19,909,000	$1,000	$1,000
Common Stock	$51,349,000	$19,909,000	$1,000	$1,000
Long Term Capital Lease Obligation	$3,026,000	$2,633,000	$0	$1,550,000
Current Capital Lease Obligation	$187,000	$0	$1,366,000	$1,061,000
Pensionand Other Post Retirement Benefit Plans Current	$8,673,000	$6,194,000	$4,666,000	-
Current Accrued Expenses	$5,156,000	$2,885,000	$4,099,000	$3,806,000
Net PPE	$36,908,000	$28,391,000	$16,723,000	$3,083,000
Accumulated Depreciation	$-23,955,000	$-17,546,000	$-7,160,000	$-1,557,000
Gross PPE	$60,863,000	$45,937,000	$23,883,000	$4,640,000
Leases	$919,000	$891,000	$872,000	$414,000
Construction In Progress	$635,000	$1,660,000	-	-
Other Properties	$57,863,000	$41,947,000	$21,540,000	$3,326,000
Machinery Furniture Equipment	$1,446,000	$1,439,000	$1,471,000	$900,000
Properties	$0	$0	$0	$0

Fetched: 2026-06-21

Cash Flow Statement (Annual)

Metric	2025-04-30	2024-04-30	2023-04-30	2021-04-30
Free Cash Flow
Free Cash Flow	$-101,199,000	$-84,749,000	$-85,103,000	$-30,231,000
Operating Activities
Operating Cash Flow	$-77,608,000	$-72,235,000	$-69,642,000	$-29,895,000
Cash Flow From Continuing Operating Activities	$-77,608,000	$-72,235,000	$-69,642,000	$-29,895,000
Operating Gains Losses	$4,742,000	$2,000,000	$560,000	$38,000
Investing Activities
Capital Expenditure	$-23,591,000	$-12,514,000	$-15,461,000	$-336,000
Investing Cash Flow	$-23,308,000	$-12,229,000	$-15,461,000	$-334,000
Cash Flow From Continuing Investing Activities	$-23,308,000	$-12,229,000	$-15,461,000	$-334,000
Net Other Investing Changes	$283,000	$285,000	-	-
Financing Activities
Issuance Of Capital Stock	$319,189,000	$75,000,000	$102,110,000	-
Financing Cash Flow	$330,262,000	$77,725,000	$96,106,000	$48,815,000
Cash Flow From Continuing Financing Activities	$330,262,000	$77,725,000	$96,106,000	$48,815,000
Net Other Financing Charges	$12,727,000	$-2,353,000	-	$29,002,000
Cash Dividends Paid	$-1,654,000	$-799,000	$-671,000	$-187,000
Net Preferred Stock Issuance	$103,400,000	$75,000,000	$102,110,000	-
Preferred Stock Issuance	$103,400,000	$75,000,000	$102,110,000	-
Net Common Stock Issuance	$215,789,000	$0	-	-
Common Stock Issuance	$215,789,000	$0	-	-
Other
Repayment Of Debt	$0	$-39,123,000	$-5,333,000	-
Issuance Of Debt	$0	$45,000,000	$0	$20,000,000
End Cash Position	$237,929,000	$8,583,000	$15,322,000	$24,854,000
Beginning Cash Position	$8,583,000	$15,322,000	$4,319,000	$6,268,000
Changes In Cash	$229,346,000	$-6,739,000	$11,003,000	$18,586,000
Net Issuance Payments Of Debt	$0	$5,877,000	$-5,333,000	$20,000,000
Net Long Term Debt Issuance	$0	$5,877,000	$-5,333,000	$20,000,000
Long Term Debt Payments	$0	$-39,123,000	$-5,333,000	-
Long Term Debt Issuance	$0	$45,000,000	$0	$20,000,000
Net PPE Purchase And Sale	$-23,591,000	$-12,514,000	$-15,461,000	$-334,000
Purchase Of PPE	$-23,591,000	$-12,514,000	$-15,461,000	$-336,000
Change In Working Capital	$-6,203,000	$3,888,000	$1,298,000	$-19,000
Change In Other Current Liabilities	$370,000	$-469,000	$-1,141,000	$-616,000
Change In Other Current Assets	$40,000	$-10,000	$16,000	$59,000
Change In Payables And Accrued Expense	$7,459,000	$7,711,000	$3,427,000	$1,980,000
Change In Accrued Expense	$4,617,000	$371,000	$1,284,000	$2,112,000
Change In Payable	$2,842,000	$7,340,000	$2,143,000	$-132,000
Change In Account Payable	$2,842,000	$7,340,000	$2,143,000	$-132,000
Change In Prepaid Assets	$-1,852,000	$331,000	$-271,000	$-1,442,000
Change In Inventory	$-3,443,000	$-1,177,000	$-733,000	-
Change In Receivables	$-8,777,000	$-2,498,000	$0	-
Changes In Account Receivables	$-8,777,000	$-2,498,000	$0	-
Other Non Cash Items	$2,671,000	$2,437,000	$6,719,000	$1,904,000
Stock Based Compensation	$24,270,000	$1,488,000	$1,209,000	$1,863,000
Provisionand Write Offof Assets	$2,694,000	$500,000	-	-
Deferred Tax	$64,000	$12,000	$-45,000	-
Deferred Income Tax	$64,000	$12,000	$-45,000	-
Depreciation Amortization Depletion	$7,968,000	$11,560,000	$4,855,000	$420,000
Depreciation And Amortization	$7,968,000	$11,560,000	$4,855,000	$420,000
Gain Loss On Investment Securities	$2,648,000	-	-	$40,000
Gain Loss On Sale Of PPE	$2,094,000	$1,070,000	$560,000	-
Net Income From Continuing Operations	$-113,814,000	$-94,120,000	$-84,238,000	$-34,101,000
Interest Paid Supplemental Data	-	$3,630,000	$0	-
Income Tax Paid Supplemental Data	-	$43,000	$12,000	$214,000
Depreciation	-	$11,560,000	$4,855,000	$420,000
Sale Of PPE	-	-	-	$2,000

Fetched: 2026-06-21